author-photo

Scot Dowden

Tom Baker Cancer Centre

14

Papers

3830

Citations

Citation Trend

Filter By

Papers (8) Sort By

Journal Conference Others

Phase II LAPACT trial of nab-paclitaxel (nab-P) plus gemcitabine (G) for patients with locally advanced pancreatic cancer (LAPC).

2018 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (26)
730PInterim health related quality of life (QoL) from LAPACT, a Phase 2 trial of nab-paclitaxel (nab-P) plus gemcitabine (G) for patients (Pts) with locally advanced pancreatic cancer (LAPC)

2017 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (0)
nab-Paclitaxel Plus Gemcitabine Versus Gemcitabine in Patients with Metastatic Pancreatic Adenocarcinoma: Canadian Subgroup Analysis of the Phase 3 MPACT Trial

2016 Advances in Therapy
Show All
- Source
- Cite
- Save
Citations (15)
Consensus statement: the 16th Annual Western Canadian Gastrointestinal Cancer Consensus Conference; Saskatoon, Saskatchewan; September 5–6, 2014

2015 Current Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine

2013 The New England Journal of Medicine
Show All
- Source
- Cite
- Save
Citations (3615)
Consensus recommendations for the use of anti- egfr therapies

2010
Show All
- Source
- Cite
- Save
Citations (0)
Consensus recommendations for the use of anti-EGFR therapies in metastatic colorectal cancer

2010 Current Oncology
Show All
- Source
- Cite
- Save
Citations (6)
Prevention and management of chemotherapy-induced diarrhea in patients with colorectal cancer: a consensus statement by the Canadian Working Group on Chemotherapy-Induced Diarrhea

2007 Current Oncology
Show All
- Source
- Cite
- Save
Citations (112)